Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	127.32	75	68.43	34.2	62.42	65.9
Short-Term Investments	46.51	21.53	117.16	270.99	367.31	100.14
Cash & Short-Term Investments	173.83	96.53	185.59	305.19	429.73	166.04
Cash Growth	22.89%	-47.99%	-39.19%	-28.98%	158.82%	-19.04%
Receivables	-	-	-	5.71	-	-
Prepaid Expenses	5.59	6.25	5.01	6.25	4.71	9.84
Total Current Assets	179.42	102.77	190.6	317.15	434.44	175.87
Property, Plant & Equipment	64.28	67.03	113.86	119.06	47.1	45.85
Other Long-Term Assets	10.1	3.21	3.92	3.52	1.03	1.01
Total Assets	253.8	173.01	308.37	439.73	482.57	222.73
Accounts Payable	1.97	1.92	2.24	1.39	2.81	4.1
Accrued Expenses	9.2	11.76	16.1	14.71	12.26	8.64
Current Portion of Long-Term Debt	-	-	-	-	-	0.1
Current Portion of Leases	10.58	10.41	13.24	1.89	4.47	4.03
Current Income Taxes Payable	0.08	0.1	0.25	1.32	0.04	-
Other Current Liabilities	0.63	0.73	0.42	2.02	1.29	2.54
Total Current Liabilities	22.46	24.91	32.25	21.32	20.87	19.41
Long-Term Leases	63.31	64.63	93.56	101.11	26.24	28.21
Other Long-Term Liabilities	-	-	1.05	1.11	1.11	0.15
Total Liabilities	85.77	89.54	126.85	123.54	48.22	47.77
Common Stock	0	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,132	1,004	985.65	964.97	937.13	560.7
Retained Earnings	-963.04	-919.78	-802.61	-648.08	-502.54	-385.03
Comprehensive Income & Other	-0.53	-0.47	-1.53	-0.71	-0.26	-0.73
Total Common Equity	168.03	83.47	181.52	316.19	434.35	174.96
Shareholders' Equity	168.03	83.47	181.52	316.19	434.35	174.96
Total Liabilities & Equity	253.8	173.01	308.37	439.73	482.57	222.73
Total Debt	73.89	75.04	106.8	102.99	30.71	32.35
Net Cash (Debt)	99.94	21.49	78.79	202.19	399.02	133.69
Net Cash Growth	98.68%	-72.72%	-61.03%	-49.33%	198.47%	-34.72%
Net Cash Per Share	6.93	2.13	7.94	20.62	46.86	20.86
Filing Date Shares Outstanding	20.8	20.75	10.06	9.88	9.78	7.97
Total Common Shares Outstanding	20.8	10.14	10.01	9.84	9.75	6.73
Working Capital	156.96	77.86	158.35	295.83	413.57	156.46
Book Value Per Share	8.08	8.23	18.13	32.14	44.53	25.99
Tangible Book Value	168.03	83.47	181.52	316.19	434.35	174.96
Tangible Book Value Per Share	8.08	8.23	18.13	32.14	44.53	25.99
Machinery	15.78	15.51	16.58	15.14	11.21	7.72
Construction In Progress	0.03	0.18	1.01	4.4	1.95	23.55
Leasehold Improvements	13.59	13.59	34.34	26.7	24.63	1.6

Source: S&P Capital IQ. Standard template. Financial Sources.